Glen King

Title: Glen King: Innovator in Gene Therapy

Introduction

Glen King is an accomplished inventor based in Rosharon, Texas, known for his significant contributions to the field of gene therapy. With a total of two patents to his name, he has focused on innovative methods to address critical health issues, particularly in cancer-bearing animals.

Latest Patents

Glen King's latest patents include groundbreaking work on gene therapy expression of growth hormone-releasing hormone (GHRH) for increasing red blood cell (RBC) count in subjects. This invention pertains to compositions and methods useful for treating anemia and other effects commonly associated with cancer. The invention involves delivering an effective amount of a nucleic acid expression construct that encodes GHRH into the tissue of an animal, allowing for the expression of the encoded gene. Another notable patent focuses on treating anemia through the administration of plasmids encoding GHRH. This method is designed to retard tumor growth and alleviate cachexia, wasting, and anemia in cancer-bearing animals.

Career Highlights

Throughout his career, Glen King has worked with prestigious institutions, including Baylor College of Medicine and Advisys, Inc. His work has significantly advanced the understanding and treatment of anemia in cancer patients, showcasing his dedication to improving health outcomes.

Collaborations

Glen has collaborated with notable professionals in his field, including Ruxandra Draghia-Akli and Robert Hunt Carpenter. These collaborations have further enriched his research and innovations.

Conclusion

Glen King's contributions to gene therapy represent a vital advancement in medical science, particularly in the treatment of anemia associated with cancer. His innovative approaches continue to inspire future research and development in this critical area of healthcare.